Aptevo Therapeutics Inc. Earnings Per Share, Basic and Diluted
Aptevo Therapeutics Inc. (APVO) reported Earnings Per Share, Basic and Diluted of -$1.55 per share for the 3-month period ending 2022-03-31, per its 10-Q filed 2022-05-12.
Discontinued › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareBasicAndDiluted · last filed 2022-05-12
- Aptevo Therapeutics Inc. earnings per share, basic and diluted for the quarter ending 2022-03-31 was -$1.55.
- Aptevo Therapeutics Inc. earnings per share, basic and diluted for the quarter ending 2021-09-30 was -$1.43.
- Aptevo Therapeutics Inc. earnings per share, basic and diluted for the quarter ending 2021-06-30 was -$1.75.
- Aptevo Therapeutics Inc. earnings per share, basic and diluted for the quarter ending 2021-03-31 was -$1.64, a 284.27% decline year-over-year.
- Aptevo Therapeutics Inc. earnings per share, basic and diluted for fiscal 2021 was -$6.07.
- Aptevo Therapeutics Inc. earnings per share, basic and diluted for fiscal 2020 was -$5.23.
- Aptevo Therapeutics Inc. earnings per share, basic and diluted for fiscal 2019 was -$13.86.
- Aptevo Therapeutics Inc. earnings per share, basic and diluted for fiscal 2018 was -$2.39, a 824.24% decline from fiscal 2017.
| Period end | Earnings Per Share, Basic and Diluted 3 month | Earnings Per Share, Basic and Diluted 3 month as first filed | Earnings Per Share, Basic and Diluted 6 month | Earnings Per Share, Basic and Diluted 6 month as first filed | Earnings Per Share, Basic and Diluted 9 month | Earnings Per Share, Basic and Diluted 12 month | Earnings Per Share, Basic and Diluted 12 month as first filed |
|---|---|---|---|---|---|---|---|
| 2022-03-31 | -$1.55 10-Q · filed 2022-05-12 | ||||||
| 2021-12-31 | -$6.07 10-K · filed 2022-03-24 | ||||||
| 2021-09-30 | -$1.43 10-Q · filed 2021-11-12 | -$4.80 10-Q · filed 2021-11-12 | |||||
| 2021-06-30 | -$1.75 10-Q · filed 2021-08-12 | -$3.39 10-Q · filed 2021-08-12 | |||||
| 2021-03-31 | -$1.64 10-Q · filed 2022-05-12 | ||||||
| 2020-12-31 | -$5.23 10-K · filed 2022-03-24 | ||||||
| 2020-09-30 | -$2.10 10-Q · filed 2021-11-12 | -$3.31 10-Q · filed 2021-11-12 | |||||
| 2020-06-30 | -$2.10 10-Q · filed 2021-08-12 | -$1.19 10-Q · filed 2021-08-12 | |||||
| 2020-03-31 | $0.89 10-Q · filed 2021-05-11 | ||||||
| 2019-12-31 | -$13.86 10-K · filed 2021-03-31 | -$0.99 10-K · filed 2020-03-25 | |||||
| 2019-09-30 | -$2.15 10-Q · filed 2020-11-10 | -$11.48 10-Q · filed 2020-11-10 | |||||
| 2019-06-30 | -$4.14 10-Q · filed 2020-08-14 | -$0.30 10-Q · filed 2019-08-09 | -$9.76 10-Q · filed 2020-08-14 | -$0.70 10-Q · filed 2019-08-09 | |||
| 2019-03-31 | -$7.64 10-Q · filed 2020-05-13 | -$0.44 10-Q · filed 2019-05-09 | |||||
| 2018-12-31 | -$2.39 10-K · filed 2020-03-25 | ||||||
| 2018-09-30 | -$0.56 10-Q · filed 2018-11-14 | -$1.77 10-Q · filed 2018-11-14 | |||||
| 2018-06-30 | -$0.58 10-Q · filed 2019-08-09 | -$1.21 10-Q · filed 2019-08-09 | |||||
| 2018-03-31 | -$0.63 10-Q · filed 2019-05-09 | ||||||
| 2017-12-31 | $0.33 10-K · filed 2019-03-18 | ||||||
| 2017-09-30 | $1.75 10-Q · filed 2018-11-14 | $0.79 10-Q · filed 2018-11-14 | |||||
| 2017-06-30 | -$0.53 10-Q · filed 2017-08-10 | -$1.01 10-Q · filed 2017-08-10 | |||||
| 2017-03-31 | -$0.48 10-Q · filed 2017-05-12 | ||||||
| 2016-12-31 | -$0.74 10-K · filed 2017-03-31 | -$5.55 10-K · filed 2018-03-13 | |||||
| 2016-09-30 | -$3.55 10-Q · filed 2017-11-13 | -$4.82 10-Q · filed 2017-11-13 | |||||
| 2016-06-30 | -$0.63 10-Q · filed 2017-08-10 | -$1.27 10-Q · filed 2017-08-10 | |||||
| 2016-03-31 | -$0.64 10-Q · filed 2017-05-12 | ||||||
| 2015-12-31 | -$0.88 10-K · filed 2017-03-31 | -$2.93 10-K · filed 2017-03-31 | |||||
| 2015-09-30 | -$0.63 10-K · filed 2017-03-31 | -$2.05 10-Q · filed 2016-11-14 | |||||
| 2015-06-30 | -$0.88 10-K · filed 2017-03-31 | -$1.42 10-Q/A · filed 2016-09-22 | |||||
| 2015-03-31 | -$0.54 10-K · filed 2017-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Onconetix, Inc. (ONCO) | United States | $0.004B | |
| Sunshine Biopharma Inc. (SBFM) | $0.003B | ||
| HCW Biologics Inc. (HCWB) | United States | $0.004B | -6.15 |
| REVELATION BIOSCIENCES, INC. (REVB) | United States | $0.004B | |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| 60 DEGREES PHARMACEUTICALS, INC. (SXTP) | United States | $0.004B | -0.59 |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B |